Results 301 to 310 of about 112,556 (314)

Virally targeted therapies for EBV-associated malignancies

Oncogene, 2003
Shannon C Kenney, Kenney Shannon C
exaly  

EBV AND HODGKIN'S CELLS

British Journal of Haematology, 1990
I, Kubonishi, T, Eguchi, T, Kanzaki, H, Muneishi, S, Yano, Y, Ohtsuki, I, Miyoshi   +6 more
openaire   +2 more sources

Progress on the EBV Front

International Journal of Epidemiology, 1980
openaire   +2 more sources

Proposed categorization of pathological states of EBV‐associated T/natural killer‐cell lymphoproliferative disorder (LPD) in children and young adults: Overlap with chronic active EBV infection and infantile fulminant EBV T‐LPD

Pathology International, 2008
Hiroshi Kimura, Tadashi Yoshino, Chul Woo Kim   +2 more
exaly  

EBV and rheumatoid arthritis

Immunology Today, 1982
openaire   +2 more sources

EBV

2017
openaire   +1 more source

Gene Expression Profiling Reveals Clear Differences Between EBV-Positive and EBV-Negative Posttransplant Lymphoproliferative Disorders

American Journal of Transplantation, 2013
G Verhoef, C De Wolf-Peeters, X Sagaert   +2 more
exaly  

EBV-Associated Lymphoproliferative Disorders: Classification and Treatment

Oncologist, 2008
Antonino Carbone, Annunziata Gloghini, Carbone Antonino   +2 more
exaly  

The spectrum of EBV infections

The Pediatric Infectious Disease Journal, 1984
openaire   +2 more sources

IL-10 knockdown with siRNA enhances the efficacy of Doxorubicin chemotherapy in EBV-positive tumors by inducing lytic cycle via PI3K/p38 MAPK/NF-kB pathway

Cancer Letters, 2019
Li Cao, Wen-Hai Feng
exaly